Inventor · disambiguated record
Kathryn Armour
Also filed as: ARMOUR KATHRYN · ARMOUR KATHRYN L · ARMOUR KATHRYN LESLEY
15 granted patents·9 pending applications·645 citations·filing 1994–2011
95Inventor score
Files withDOW CHEMICAL CO8IMMUNOMEDICS INC3SLOAN KETTERING INST CANCER2ARMOUR KATHRYN L1ARMOUR KATHRYN LESLEY1
Top patents by PatentIndex Score
24 records- 0197US5874540ACDR-grafted type III anti-CEA humanized mouse monoclonal antibodiesIMMUNOMEDICS INC·Filed 1994·Granted Feb 23, 1999·201 cites·30 claims
- 0293US6676924B2CDR-grafted type III anti-CEA humanized mouse monoclonal antibodiesIMMUNOMEDICS INC·Filed 1999·Granted Jan 13, 2004·86 cites·27 claims
- 0393US6333405B1High affinity humanized anti-CEA monoclonal antibodiesDOW CHEMICAL CO·Filed 2000·Granted Dec 25, 2001·28 cites·5 claims
- 0493US6310185B1Recombinant human anti-Lewis Y antibodiesSLOAN KETTERING INST CANCER·Filed 1994·Granted Oct 30, 2001·112 cites·6 claims
- 0588US6417337B1High affinity humanized anti-CEA monoclonal antibodiesDOW CHEMICAL CO·Filed 1998·Granted Jul 9, 2002·42 cites·8 claims
- 0687US5874060ARecombinant human anti-Lewis Y antibodiesSLOAN KETTERING INST CANCER·Filed 1997·Granted Feb 23, 1999·49 cites·7 claims
- 0783US6753420B2High affinity humanized anti-Tag-72 monoclonal antibodiesDOW CHEMICAL CO·Filed 2001·Granted Jun 22, 2004·5 cites·4 claims
- 0881US7597889B1Binding molecules derived from immunoglobulins which do not trigger complement mediated lysisCAMBRIDGE ENTPR LTD·Filed 1999·Granted Oct 6, 2009·68 cites·52 claims
- 0981US6348581B1High affinity humanized anti-TAG-72 monoclonalantibodiesDOW CHEMICAL CO·Filed 1998·Granted Feb 19, 2002·24 cites·6 claims
- 1066US2005215768A1Polypeptides including modified constant regionsARMOUR KATHRYN L·Filed 2004·Application pending·0 cites
- 1165US6518415B1Recombinant human anti-Lewis Y antibodiesLUDWIG INST CANCER RES·Filed 1997·Granted Feb 11, 2003·11 cites·24 claims
- 1264US5607847ARecombinant human anti-human immunodeficiency virus antibodyNISSIN FOOD PRODUCTS LTD·Filed 1994·Granted Mar 4, 1997·19 cites·6 claims
- 1364US2005089538A1CDR grafted type III anti-CEA humanized mouse monoclonal antibodiesIMMUNOMEDICS INC·Filed 2004·Application pending·0 cites
- 1461US6753152B2High affinity humanized anti-tag-72 monoclonalantibodiesDOW CHEMICAL CO·Filed 2001·Granted Jun 22, 2004·0 cites·5 claims
- 1561US6752990B2High affinity humanized anti-TAG-72 monoclonal antibodiesDOW CHEMICAL CO·Filed 2001·Granted Jun 22, 2004·0 cites·3 claims
- 1661US6737060B2High affinity humanized anti-TAG-72 monoclonal antibodiesDOW CHEMICAL CO·Filed 2001·Granted May 18, 2004·0 cites·3 claims
- 1761US6737061B2High affinity humanized anti-TAG-72 monoclonal antibodiesDOW CHEMICAL CO·Filed 2001·Granted May 18, 2004·0 cites·4 claims
- 1860US2007041966A1Polypeptides including modified constant regionsXENCOR INC·Filed 2006·Application pending·0 cites
- 1959US2002165387A1High affinity humanized anti-CEA monoclonal antibodiesFiled 2001·Application pending·0 cites
- 2059US2003027994A1High affinity humanized anti-CEA monoclonal antibodiesFiled 2001·Application pending·0 cites
- 2159US2002183495A1High affinity humanized anti-CEA monoclonal antibodiesFiled 2001·Application pending·0 cites
- 2258US2003018171A1High affinity humanized anti-CEA monoclonal antibodiesFiled 2001·Application pending·0 cites
- 2358US2012039907A1Polypeptides including modified constant regionsARMOUR KATHRYN LESLEY·Filed 2011·Application pending·0 cites
- 2455US2010247431A1Polypeptides including modified constant regionsUNIV CAMBRIDGE TECH·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →